Jounce Therapeutics Inc. (NASDAQ: JNCE) made a massive gain on Tuesday after the company announced a licensing agreement with Gilead Sciences Inc. (NASDAQ: GILD). This deal is for the discovery and development of novel…
Plus Therapeutics shares rallied on Tuesday after an FDA update on its treatment of patients with recurrent glioblastoma.
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but none are approved yet.
The prize for Nestle in its acquisition of Aimmune Therapeutics is Palforzia, the world’s first treatment for a food allergy.
Akcea Therapeutics stock jumped on Monday after it was announced that Ionis Pharmaceuticals would be acquiring all of its outstanding shares.
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week trading highs and are offering…
Fluidigm made a splash with the markets on Wednesday morning after the company announced a critical update from the FDA in regards to its COVID-19 test.
Independent research firm Argus has reiterated its Buy rating on Moderna and is calling this large pullback a buying opportunity.
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Medtronic reported better than expected quarterly results before the markets opened on Tuesday.
Has the COVID-19 pandemic discouraged bystanders from helping a person who may be suffering from a heart attack?
Cancer Genetics shares more than doubled on Monday after the company announced a merger with StemoniX.
Onconova Therapeutics stock was absolutely crushed to start out the week after the company reported results from its late-stage cancer study.
What are India's real confirmed case and death numbers? No one will ever know. A low testing rate and poor procedures for providing COVID-19 deaths mean the numbers are wildly low.
Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and testing.
